{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:40:14Z","timestamp":1783003214184,"version":"3.54.5"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81822002"],"award-info":[{"award-number":["81822002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91439203"],"award-info":[{"award-number":["91439203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630010"],"award-info":[{"award-number":["81630010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771264"],"award-info":[{"award-number":["31771264"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31571197"],"award-info":[{"award-number":["31571197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31800973"],"award-info":[{"award-number":["31800973"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12933-018-0767-z","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T11:06:01Z","timestamp":1536059161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin"],"prefix":"10.1186","volume":"17","author":[{"given":"Beibei","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"767_CR1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/414782a","volume":"414","author":"P Zimmet","year":"2001","unstructured":"Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782\u20137.","journal-title":"Nature"},{"issue":"5","key":"767_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/01.RES.0000207406.94146.c2","volume":"98","author":"IG Poornima","year":"2006","unstructured":"Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res. 2006;98(5):596\u2013605.","journal-title":"Circ Res"},{"issue":"3","key":"767_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","volume":"142","author":"K Huynh","year":"2014","unstructured":"Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther. 2014;142(3):375\u2013415.","journal-title":"Pharmacol Ther"},{"key":"767_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000064682","volume":"98","author":"CM Schannwell","year":"2002","unstructured":"Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002;98:33\u20139.","journal-title":"Cardiology"},{"issue":"2","key":"767_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0735-1097(03)00625-9","volume":"42","author":"M Diamant","year":"2003","unstructured":"Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JWA, Bax JJ, Romijn JA, de Roos A, Radder JK. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol. 2003;42(2):328\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"767_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.diabres.2007.09.014","volume":"79","author":"V Palmieri","year":"2008","unstructured":"Palmieri V, Capaldo B, Russo C, Iaccarino M, Pezzullo S, Quintavalle G, Di Minno G, Riccardi G, Celentano A. Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. Diabetes Res Clin Pract. 2008;79(2):262\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"767_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCHEARTFAILURE.113.000672","volume":"7","author":"J Mori","year":"2014","unstructured":"Mori J, Patel VB, Abo Alrob O, Basu R, Altamimi T, Desaulniers J, Wagg CS, Kassiri Z, Lopaschuk GD, Oudit GY. Angiotensin 1\u20137 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db\/db mice by reducing lipotoxicity and inflammation. Circ Heart Fail. 2014;7(2):327\u201339.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"767_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","volume":"117","author":"L Heerebeek van","year":"2008","unstructured":"van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117(1):43\u201351.","journal-title":"Circulation"},{"key":"767_CR9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/heart.83.5.596","volume":"83","author":"JJ McMurray","year":"2000","unstructured":"McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000;83:596\u2013602.","journal-title":"Heart"},{"key":"767_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0002-9149(00)01393-X","volume":"87","author":"DW Kitzman","year":"2001","unstructured":"Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R. Importance of heart failure with preserved systolic function in patients\u2009>\u200965\u00a0years of age. Am J Cardiol. 2001;87:413\u20139.","journal-title":"Am J Cardiol"},{"key":"767_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1161\/01.CIR.101.8.899","volume":"101","author":"M Katsufumi","year":"2000","unstructured":"Katsufumi M, Li Y, Takahisa N, Hideyasu K, Yang Y, Naohisa H, Koji O, Hirohide M. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation. 2000;101:899\u2013907.","journal-title":"Circulation"},{"key":"767_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.freeradbiomed.2013.02.021","volume":"60","author":"K Huynh","year":"2013","unstructured":"Huynh K, Kiriazis H, Du XJ, Love JE, Gray SP, Jandeleit-Dahm KA, McMullen JR, Ritchie RH. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free Radic Biol Med. 2013;60:307\u201317.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"767_CR13","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s00125-012-2495-3","volume":"55","author":"K Huynh","year":"2012","unstructured":"Huynh K, Kiriazis H, Du XJ, Love JE, Jandeleit-Dahm KA, Forbes JM, McMullen JR, Ritchie RH. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db\/db mouse model of type 2 diabetes. Diabetologia. 2012;55(5):1544\u201353.","journal-title":"Diabetologia"},{"issue":"6","key":"767_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/HYPERTENSIONAHA.115.06015","volume":"66","author":"G Jia","year":"2015","unstructured":"Jia G, Habibi J, DeMarco VG, Martinez-Lemus LA, Ma L, Whaley-Connell AT, Aroor AR, Domeier TL, Zhu Y, Meininger GA, et al. Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females. Hypertension. 2015;66(6):1159\u201367.","journal-title":"Hypertension"},{"key":"767_CR15","doi-asserted-by":"publisher","first-page":"E923","DOI":"10.1152\/ajpendo.00360.2002","volume":"284","author":"LL Atkinson","year":"2003","unstructured":"Atkinson LL, Kozak R, Kelly SE, Besikci AO, Russell JC, Lopaschuk GD. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. Am J Physiol Endocrinol Metab. 2003;284:E923\u201330.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"767_CR16","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.2337\/db12-1391","volume":"62","author":"S Lei","year":"2013","unstructured":"Lei S, Li H, Xu J, Liu Y, Gao X, Wang J, Ng KF, Lau WB, Ma XL, Rodrigues B, et al. Hyperglycemia-induced protein kinase C beta2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt\/eNOS signaling. Diabetes. 2013;62(7):2318\u201328.","journal-title":"Diabetes"},{"issue":"2","key":"767_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/CIRCRESAHA.110.227496","volume":"108","author":"E Rooij van","year":"2011","unstructured":"van Rooij E. The art of microRNA research. Circ Res. 2011;108(2):219\u201334.","journal-title":"Circ Res"},{"issue":"11","key":"767_CR18","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","volume":"118","author":"MS Shah","year":"2016","unstructured":"Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res. 2016;118(11):1808\u201329.","journal-title":"Circ Res"},{"issue":"1","key":"767_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-017-0638-z","volume":"16","author":"J Russell","year":"2017","unstructured":"Russell J, Du Toit EF, Peart JN, Patel HH, Headrick JP. Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection. Cardiovasc Diabetol. 2017;16(1):155.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"767_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12933-016-0390-9","volume":"15","author":"L Sala La","year":"2016","unstructured":"La Sala L, Cattaneo M, De Nigris V, Pujadas G, Testa R, Bonfigli AR, Genovese S, Ceriello A. Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells. Cardiovasc Diabetol. 2016;15(1):71.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"767_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/cvr\/cvr145","volume":"92","author":"H Zhu","year":"2011","unstructured":"Zhu H, Yang Y, Wang Y, Li J, Schiller PW, Peng T. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res. 2011;92(1):75\u201384.","journal-title":"Cardiovasc Res"},{"key":"767_CR22","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","volume":"5","author":"X Li","year":"2014","unstructured":"Li X, Du N, Zhang Q, Li J, Chen X, Liu X, Hu Y, Qin W, Shen N, Xu C, et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014;5:e1479.","journal-title":"Cell Death Dis"},{"issue":"2","key":"767_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","volume":"116","author":"Y Kuwabara","year":"2015","unstructured":"Kuwabara Y, Horie T, Baba O, Watanabe S, Nishiga M, Usami S, Izuhara M, Nakao T, Nishino T, Otsu K, et al. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway. Circ Res. 2015;116(2):279\u201388.","journal-title":"Circ Res"},{"key":"767_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.omtn.2017.03.005","volume":"7","author":"C Chen","year":"2017","unstructured":"Chen C, Yang S, Li H, Yin Z, Fan J, Zhao Y, Gong W, Yan M, Wang DW. MiR-30c is involved in diabetic cardiomyopathy through regulation of cardiac autophagy via BECN1. Mol Ther Nucleic Acids. 2017;7:127\u201339.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"06","key":"767_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4172\/2155-9929.1000251","volume":"06","author":"A Villard","year":"2015","unstructured":"Villard A, Marchand L. Diagnostic value of cell-free circulating micrornas for obesity and type 2 diabetes: a meta-analysis. J Mol Biomark Diagn. 2015;06(06):251.","journal-title":"J Mol Biomark Diagn"},{"key":"767_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0600-0","volume":"16","author":"A Giannella","year":"2017","unstructured":"Giannella A, Radu CM, Franco L, Campello E, Simioni P, Avogaro A, de Kreutzenberg SV, Ceolotto G. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance. Cardiovasc Diabetol. 2017;16:1.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"767_CR27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","volume":"107","author":"A Zampetaki","year":"2010","unstructured":"Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107(6):810\u20137.","journal-title":"Circ Res"},{"key":"767_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12933-016-0367-8","volume":"15","author":"F Jansen","year":"2016","unstructured":"Jansen F, Wang H, Przybilla D, Franklin BS, Dolf A, Pfeifer P, Schmitz T, Flender A, Endl E, Nickenig G, et al. Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Cardiovasc Diabetol. 2016;15:49.","journal-title":"Cardiovasc Diabetol"},{"key":"767_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12933-016-0484-4","volume":"16","author":"JK Pearson","year":"2017","unstructured":"Pearson JK. Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways. Cardiovasc Diabetol. 2017;16:10.","journal-title":"Cardiovasc Diabetol"},{"key":"767_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-016-0361-1","volume":"15","author":"V Kandula","year":"2016","unstructured":"Kandula V, Kosuru R, Li H, Yan D, Zhu Q, Lian Q, Ge RS, Xia Z, Irwin MG. Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy. Cardiovasc Diabetol. 2016;15:44.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"767_CR31","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1002\/oby.20852","volume":"22","author":"T Seeger","year":"2014","unstructured":"Seeger T, Fischer A, Muhly-Reinholz M, Zeiher AM, Dimmeler S. Long-term inhibition of miR-21 leads to reduction of obesity in db\/db mice. Obesity (Silver Spring). 2014;22(11):2352\u201360.","journal-title":"Obesity (Silver Spring)"},{"key":"767_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2741\/e802","volume":"9","author":"MB Lopes","year":"2017","unstructured":"Lopes MB, Freitas RC, Hirata MH, Hirata RD, Rezende AA, Silbiger VN, Bortolin RH, Luchessi AD. mRNA\u2013miRNAintegrativeanalysisofdiabetes-inducedcardiomyopathyinrats. Front Biosci. 2017;9:194\u2013229.","journal-title":"Front Biosci"},{"issue":"7224","key":"767_CR33","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456(7224):980\u20134.","journal-title":"Nature"},{"issue":"1","key":"767_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.yjmcc.2009.01.008","volume":"47","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol. 2009;47(1):5\u201314.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"767_CR35","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cjca.2014.07.747","volume":"30","author":"S Liu","year":"2014","unstructured":"Liu S, Li W, Xu M, Huang H, Wang J, Chen X. Micro-RNA 21Targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts. Can J Cardiol. 2014;30(12):1689\u201399.","journal-title":"Can J Cardiol"},{"issue":"9","key":"767_CR36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/s-0032-1311644","volume":"120","author":"HY Ling","year":"2012","unstructured":"Ling HY, Hu B, Hu XB, Zhong J, Feng SD, Qin L, Liu G, Wen GB, Liao DF. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue. Exp Clin Endocrinol Diabetes. 2012;120(9):553\u20139.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"767_CR37","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1038\/mt.2016.166","volume":"24","author":"D Ramanujam","year":"2016","unstructured":"Ramanujam D, Sassi Y, Laggerbauer B, Engelhardt S. Viral vector-based targeting of mir-21 in cardiac nonmyocyte cells reduces pathologic remodeling of the heart. Mol Ther. 2016;24(11):1939\u201348.","journal-title":"Mol Ther"},{"issue":"6","key":"767_CR38","doi-asserted-by":"publisher","first-page":"e65809","DOI":"10.1371\/journal.pone.0065809","volume":"8","author":"F Martelli","year":"2013","unstructured":"Martelli F, McGahon MK, Yarham JM, Daly A, Guduric-Fuchs J, Ferguson LJ, Simpson DA, Collins A. Distinctive profile of IsomiR expression and novel MicroRNAs in rat heart left ventricle. PLoS ONE. 2013;8(6):e65809.","journal-title":"PLoS ONE"},{"issue":"10","key":"767_CR39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.116.023926","volume":"134","author":"H Li","year":"2016","unstructured":"Li H, Zhang X, Wang F, Zhou L, Yin Z, Fan J, Nie X, Wang P, Fu XD, Chen C, et al. MicroRNA-21 lowers blood pressure in spontaneous hypertensive rats by upregulating mitochondrial translation. Circulation. 2016;134(10):734\u201351.","journal-title":"Circulation"},{"issue":"2","key":"767_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.bbamcr.2014.11.015","volume":"1853","author":"AV Kuznetsov","year":"2015","unstructured":"Kuznetsov AV, Javadov S, Sickinger S, Frotschnig S, Grimm M. H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation. Biochimica et Biophysica Acta (BBA). 2015;1853(2):276\u201384.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"767_CR41","first-page":"e50289","volume":"79","author":"EL Graham","year":"2013","unstructured":"Graham EL, Balla C, Franchino H, Melman Y, del Monte F, Das S. Isolation, culture, and functional characterization of adult mouse cardiomyoctyes. J Vis Exp. 2013;79:e50289.","journal-title":"J Vis Exp"},{"issue":"4","key":"767_CR42","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cmet.2015.02.014","volume":"21","author":"X Liu","year":"2015","unstructured":"Liu X, Xiao J, Zhu H, Wei X, Platt C, Damilano F, Xiao C, Bezzerides V, Bostrom P, Che L, et al. miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab. 2015;21(4):584\u201395.","journal-title":"Cell Metab"},{"issue":"7","key":"767_CR43","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.4161\/auto.20260","volume":"8","author":"YM Song","year":"2012","unstructured":"Song YM, Song SO, Jung YK, Kang ES, Cha BS, Lee HC, Lee BW. Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction. Autophagy. 2012;8(7):1085\u201397.","journal-title":"Autophagy"},{"issue":"4","key":"767_CR44","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCRESAHA.108.185363","volume":"104","author":"X Liu","year":"2009","unstructured":"Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 2009;104(4):476\u201387.","journal-title":"Circ Res"},{"issue":"1","key":"767_CR45","first-page":"192","volume":"8","author":"Z Yin","year":"2016","unstructured":"Yin Z, Zhao Y, Li H, Yan M, Zhou L, Chen C, Wang DW. MiR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway. Ageing. 2016;8(1):192.","journal-title":"Ageing"},{"issue":"14","key":"767_CR46","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1158\/0008-5472.CAN-06-3643","volume":"67","author":"JG Jiang","year":"2007","unstructured":"Jiang JG, Ning YG, Chen C, Ma D, Liu ZJ, Yang S, Zhou J, Xiao X, Zhang XA, Edin ML, et al. Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res. 2007;67(14):6665\u201374.","journal-title":"Cancer Res"},{"key":"767_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/cvr\/cvw048","volume":"110","author":"Z Hu","year":"2016","unstructured":"Hu Z, Crump SM, Zhang P, Abbott GW. Kcne2 deletion attenuates acute post-ischaemia\/reperfusion myocardial infarction. Cardiovasc Res. 2016;110:227\u201337.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"767_CR48","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00380-017-0978-3","volume":"32","author":"PV Dludla","year":"2017","unstructured":"Dludla PV, Essop MF, Gabuza KB, Muller CJF, Louw J, Johnson R. Age-dependent development of left ventricular wall thickness in type 2 diabetic (db\/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels. Heart Vessels. 2017;32(8):1025\u201331.","journal-title":"Heart Vessels"},{"issue":"5","key":"767_CR49","doi-asserted-by":"publisher","first-page":"H729","DOI":"10.1152\/ajpheart.00638.2012","volume":"304","author":"RH Ritchie","year":"2013","unstructured":"Ritchie RH, Leo CH, Qin C, Stephenson EJ, Bowden MA, Buxton KD, Lessard SJ, Rivas DA, Koch LG, Britton SL, et al. Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function. Am J Physiol Heart Circ Physiol. 2013;304(5):H729\u201339.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"767_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pharmthera.2015.03.002","volume":"151","author":"L Murfitt","year":"2015","unstructured":"Murfitt L, Whiteley G, Iqbal MM, Kitmitto A. Targeting caveolin-3 for the treatment of diabetic cardiomyopathy. Pharmacol Ther. 2015;151:50\u201371.","journal-title":"Pharmacol Ther"},{"issue":"11","key":"767_CR51","doi-asserted-by":"publisher","first-page":"e50376","DOI":"10.1371\/journal.pone.0050376","volume":"7","author":"T Peng","year":"2012","unstructured":"Peng T, Yang S, Chen C, Wang H, Rao X, Wang F, Duan Q, Chen F, Long G, Gong W, et al. Protective effects of Acyl-coA thioesterase 1 on diabetic heart via PPAR\u03b1\/PGC1\u03b1 signaling. PLoS ONE. 2012;7(11):e50376.","journal-title":"PLoS ONE"},{"issue":"9","key":"767_CR52","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4330\/wjc.v7.i9.511","volume":"7","author":"ME Hall","year":"2015","unstructured":"Hall ME, Harmancey R, Stec DE. Lean heart: role of leptin in cardiac hypertrophy and metabolism. World J Cardiol. 2015;7(9):511\u201324.","journal-title":"World J Cardiol"},{"issue":"2","key":"767_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1152\/physrev.00017.2007","volume":"88","author":"ED Abel","year":"2008","unstructured":"Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008;88(2):389\u2013419.","journal-title":"Physiol Rev"},{"key":"767_CR54","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1152\/ajpendo.2000.279.5.E1104","volume":"279","author":"DD Belke","year":"2000","unstructured":"Belke DD, Larsen TS, Gibbs EM, David LS. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db\/db) mice. Am J Physiol Endocrinol Metab. 2000;279:1104\u201313.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"767_CR55","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/01.RES.0000266449.37396.1f","volume":"100","author":"W Hsueh","year":"2007","unstructured":"Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, Dansky H, McClain DA, McIndoe R, Wassef MK, et al. Recipes for creating animal models of diabetic cardiovascular disease. Circ Res. 2007;100(10):1415\u201327.","journal-title":"Circ Res"},{"issue":"6","key":"767_CR56","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2337\/db09-1456","volume":"59","author":"K Huynh","year":"2010","unstructured":"Huynh K, McMullen JR, Julius TL, Tan JW, Love JE, Cemerlang N, Kiriazis H, Du XJ, Ritchie RH. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes. 2010;59(6):1512\u201320.","journal-title":"Diabetes"},{"issue":"4","key":"767_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25(4):543\u201367.","journal-title":"Endocr Rev"},{"issue":"2","key":"767_CR58","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/cvr\/cvm001","volume":"77","author":"A Bergh Van den","year":"2008","unstructured":"Van den Bergh A, Vanderper A, Vangheluwe P, Desjardins F, Nevelsteen I, Verreth W, Wuytack F, Holvoet P, Flameng W, Balligand J-L, et al. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc Res. 2008;77(2):371\u20139.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"767_CR59","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/eurjhf\/hfp156","volume":"11","author":"A Bergh Van den","year":"2009","unstructured":"Van den Bergh A, Vangheluwe P, Vanderper A, Carmeliet P, Wuytack F, Janssens S, Flameng W, Holvoet P, Herijgers P. Food-restriction in obese dyslipidaemic diabetic mice partially restores basal contractility but not contractile reserve. Eur J Heart Fail. 2009;11(12):1118\u201325.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"767_CR60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3892\/mmr.2014.2205","volume":"10","author":"HF Xu","year":"2014","unstructured":"Xu HF, Ding YJ, Zhang ZX, Wang ZF, Luo CL, Li BX, Shen YW, Tao LY, Zhao ZQ. MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Rep. 2014;10(1):161\u20138.","journal-title":"Mol Med Rep"},{"issue":"6","key":"767_CR61","doi-asserted-by":"publisher","first-page":"890","DOI":"10.4161\/cc.28189","volume":"13","author":"Z Cheng","year":"2014","unstructured":"Cheng Z, Almeida F. Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link. Cell Cycle. 2014;13(6):890\u20137.","journal-title":"Cell Cycle"},{"issue":"12","key":"767_CR62","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1089\/hum.2008.123","volume":"19","author":"LT Bish","year":"2008","unstructured":"Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, Gao G, Wilson JM, Sweeney HL. Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther. 2008;19(12):1359\u201368.","journal-title":"Hum Gene Ther"},{"issue":"8","key":"767_CR63","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1089\/hum.2017.188","volume":"29","author":"K Chamberlain","year":"2018","unstructured":"Chamberlain K, Riyad JM, Garnett T, Kohlbrenner E, Mookerjee A, Elmastour F, Benard L, Chen J, VandenDriessche T, Chuah MK et al. A calsequestrin cis-regulatory motif coupled to a cardiac troponin t promoter improves cardiac adeno-associated virus serotype 9 transduction specificity. Hum Gene Ther. 2018;29(8):927\u201337.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"767_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gt.2010.105","volume":"18","author":"KMR Prasad","year":"2010","unstructured":"Prasad KMR, Xu Y, Yang Z, Acton ST, French BA. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther. 2010;18(1):43\u201352.","journal-title":"Gene Ther"},{"issue":"1","key":"767_CR65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cvr\/cvu174","volume":"104","author":"S Werfel","year":"2014","unstructured":"Werfel S, Jungmann A, Lehmann L, Ksienzyk J, Bekeredjian R, Kaya Z, Leuchs B, Nordheim A, Backs J, Engelhardt S, et al. Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase. Cardiovasc Res. 2014;104(1):15\u201323.","journal-title":"Cardiovasc Res"},{"key":"767_CR66","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1677\/jme.0.0310449","volume":"31","author":"SJ Kaczmarczyk","year":"2003","unstructured":"Kaczmarczyk SJ, Andrikopoulos S, Favaloro J. Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy. J Mol Endocrinol. 2003;31:449\u201359.","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"767_CR67","doi-asserted-by":"publisher","first-page":"H270","DOI":"10.1152\/ajpheart.00852.2002","volume":"285","author":"TA Hopkins","year":"2003","unstructured":"Hopkins TA, Sugden MC, Holness MJ, Kozak R, Dyck JRB, Lopaschuk GD. Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-\u03b1 transgenic mice. Am J Physiol Heart Circ Physiol. 2003;285(1):H270\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"767_CR68","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.bbalip.2006.08.010","volume":"1761","author":"S Ghosh","year":"2006","unstructured":"Ghosh S, Rodrigues B. Cardiac cell death in early diabetes and its modulation by dietary fatty acids. Biochim Biophys Acta. 2006;1761(10):1148\u201362.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"767_CR69","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","volume":"15","author":"IJ Goldberg","year":"2012","unstructured":"Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab. 2012;15(6):805\u201312.","journal-title":"Cell Metab"},{"issue":"3","key":"767_CR70","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbalip.2009.09.023","volume":"1801","author":"AR Wende","year":"2010","unstructured":"Wende AR, Abel ED. Lipotoxicity in the heart. Biochim Biophys Acta. 2010;1801(3):311\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"767_CR71","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1161\/01.CIR.102.25.3046","volume":"102","author":"J Yang","year":"2000","unstructured":"Yang J, Moravec CS, Sussman MA, DiPaola NR. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation. 2000;102:3046\u201352.","journal-title":"Circulation"},{"issue":"7","key":"767_CR72","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/CIRCRESAHA.108.172882","volume":"104","author":"GH Li","year":"2009","unstructured":"Li GH, Shi Y, Chen Y, Sun M, Sader S, Maekawa Y, Arab S, Dawood F, Chen M, De Couto G, et al. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis. Circ Res. 2009;104(7):896\u2013904.","journal-title":"Circ Res"},{"issue":"1","key":"767_CR73","doi-asserted-by":"publisher","first-page":"H314","DOI":"10.1152\/ajpheart.00085.2008","volume":"295","author":"SK Mani","year":"2008","unstructured":"Mani SK, Shiraishi H, Balasubramanian S, Yamane K, Chellaiah M, Cooper G, Banik N, Zile MR, Kuppuswamy D. In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium. Am J Physiol Heart Circ Physiol. 2008;295(1):H314\u201326.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1\u20132","key":"767_CR74","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11010-014-1977-7","volume":"390","author":"WS Hu","year":"2014","unstructured":"Hu WS, Ho TJ, Pai P, Chung LC, Kuo CH, Chang SH, Tsai FJ, Tsai CH, Jie YC, Liou YM, et al. Gelsolin (GSN) induces cardiomyocyte hypertrophy and BNP expression via p38 signaling and GATA-4 transcriptional factor activation. Mol Cell Biochem. 2014;390(1\u20132):263\u201370.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"767_CR75","first-page":"373","volume":"66","author":"JKH Weisser-thomas","year":"2015","unstructured":"Weisser-thomas JKH, Nickenig G, Grohe C, Djoufack P. Influence of gelsolin deficiency on excitation contraction coupling in adult murine cardiomyocytes. J Physiol Pharmacol. 2015;66(3):373\u201383.","journal-title":"J Physiol Pharmacol"},{"issue":"2","key":"767_CR76","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbrc.2009.05.078","volume":"385","author":"Q Li","year":"2009","unstructured":"Li Q, Ye Z, Wen J, Ma L, He Y, Lian G, Wang Z, Wei L, Wu D, Jiang B. Gelsolin, but not its cleavage, is required for TNF-induced ROS generation and apoptosis in MCF-7 cells. Biochem Biophys Res Commun. 2009;385(2):284\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"33","key":"767_CR77","doi-asserted-by":"crossref","first-page":"52832","DOI":"10.18632\/oncotarget.10451","volume":"7","author":"L Tochhawng","year":"2015","unstructured":"Tochhawng L, Deng S, Pugalenthi G, Kumar AP. Gelsolin-CuZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasion. Oncotarget. 2015;7(33):52832\u201348.","journal-title":"Oncotarget"},{"issue":"6736","key":"767_CR78","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/21218","volume":"399","author":"D Fulton","year":"1999","unstructured":"Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399(6736):597\u2013601.","journal-title":"Nature"},{"issue":"4","key":"767_CR79","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","volume":"116","author":"G Heusch","year":"2015","unstructured":"Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015;116(4):674\u201399.","journal-title":"Circ Res"},{"issue":"1","key":"767_CR80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/FJC.0b013e3181c87a82","volume":"55","author":"H Fukushima","year":"2010","unstructured":"Fukushima H, Kobayashi N, Takeshima H, Koguchi W, Ishimitsu T. Effects of olmesartan on Apelin\/APJ and Akt\/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure. J Cardiovasc Pharmacol. 2010;55(1):83\u20138.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"767_CR81","doi-asserted-by":"publisher","first-page":"R793","DOI":"10.1152\/ajpregu.00713.2007","volume":"294","author":"J Ren","year":"2008","unstructured":"Ren J, Duan J, Thomas DP, Yang X, Sreejayan N, Sowers JR, Leri A, Kajstura J, Gao F, Anversa P. IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction. Am J Physiol Regul Integr Comp Physiol. 2008;294(3):R793\u2013802.","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-018-0767-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-018-0767-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-018-0767-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T21:52:28Z","timestamp":1604872348000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-018-0767-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1186\/s12933-018-0767-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"123"}}